Parkinson's disease therapeutics (Berg Pharma/AstraZeneca)

N/A

Report date: 2025/03/20 09:59:19
NME

Base Information

Drug NameParkinson's disease therapeutics (Berg Pharma/AstraZeneca)
Drug Alias NameParkinson's disease therapeutics (Berg Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBerg Llc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcBerg Llc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A